Clinical Trial Update: Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is investigating the efficacy and safety of IL-1 inhibitors for mild to moderate systemic lupus erythematosus and is not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• IL-1 inhibitors

Snippet

Sponsor: Chinese SLE Treatment And Research Group | Conditions: Lupus Erythematosus, Systemic | Phase 4 | Status: NOT_YET_RECRUITING